- Home
- ANGO vs DHIL Comparison
ANGO vs DHIL Comparison
Compare ANGO & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANGO | DHIL |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.0M | 463.8M |
| IPO Year | 2004 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANGO | DHIL |
|---|---|---|
| Price | $10.77 | $172.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.33 | N/A |
| AVG Volume (30 Days) | ★ 324.2K | 21.4K |
| Earning Date | 04-07-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 3.48% |
| EPS Growth | ★ 81.92 | 14.37 |
| EPS | N/A | ★ 17.91 |
| Revenue | ★ $291,010,000.00 | $145,201,729.00 |
| Revenue This Year | $9.11 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | ★ 10.17 | 6.69 |
| 52 Week Low | $8.27 | $114.11 |
| 52 Week High | $13.99 | $173.00 |
Technical Indicators
Market Signals| Indicator | ANGO | DHIL |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 66.08 |
| Support Level | $10.37 | $170.59 |
| Resistance Level | $11.03 | N/A |
| Average True Range (ATR) | 0.33 | 0.69 |
| MACD | -0.03 | -0.19 |
| Stochastic Oscillator | 21.55 | 70.12 |
Price Performance
Historical ComparisonAbout ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.